Abstract Objective To study the expression of leukocyte-associated Ig-like receptor-1(LAIR-1) in children with immune thrombocytopenia (ITP), in order to explore the possible role of LAIR-1 in the pathogenesis of childhood ITP. Methods Expression levels of LAIR-1 on CD4+ T cells, CD8+ T cells and CD19+CD20+ B cells of peripheral blood were measured in 40 children with ITP by flow cytometry. Serum level of solubility LAIR-1 (sLAIR-1) was measured using ELISA. Real-time PCR was used to measure LAIR-1 mRNA expression. Thirty-two healthy children served as the control group. Results The percentages of CD19+CD20+ B cells in the ITP group were significantly higher than in the control group (P+ T cells in the ITP group was significantly lower than in the control group (P+ T cells and CD8+ T cells were significantly lower in the ITP group than in the control group (PPConclusions LAIR-1 expression on CD4+ and CD8+ T cells decreases and serum sLAIR-1 level increases in children with ITP, suggesting that LAIR-1 may play an important role in immune imbalance in these children.
HUANG Mei-Ling,LI Chang-Gang,WANG Guo-Bing et al. Expression of leukocyte-associated Ig-like receptor-1 in children with immune thrombocytopenia[J]. CJCP, 2014, 16(4): 370-374.
HUANG Mei-Ling,LI Chang-Gang,WANG Guo-Bing et al. Expression of leukocyte-associated Ig-like receptor-1 in children with immune thrombocytopenia[J]. CJCP, 2014, 16(4): 370-374.
McMillan R. The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura[J]. Curr Hematol Rep, 2005, 4(2): 160-165.
Walk J, Westerlaken GH, van Uden NO, et al. Inhibitory receptor expression on neonatal immune cells[J]. Clin Exp Immunol, 2012, 169(2): 164-171.
[4]
Jansen CA, Cruijsen CW, de Ruiter T, et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation[J]. J Immunol, 2007, 37(4): 914-924.
[5]
Olde Nordkamp MJ, van Roon JA, Douwes M, et al. Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis[J]. Arthritis Rheum, 2011, 63(12): 3749-3757.
[6]
Zhang Y, Ding Y, Huang Y, et al. Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis[J]. Clinics (Sao Paulo), 2013, 68(4): 475-481.
[7]
Colombo BM, Canevali P, Magnani O, et al. Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients[J]. PLoS ONE, 2012, 7(2): e31903.
[8]
Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group[J]. Blood, 2009, 113(11): 2386-2393.
Zhang J, Ma D, Zhu X, et al. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura[J]. Haematologica, 2009, 94(9): 1326-1329.
[13]
Meyaard L. LAIR and collagens in immune regulation[J]. Immunol Lett, 2010, 128(1): 26-28.
[14]
Maasho K, Masilamani M, Valas R, et al. The inhibitory leukocyte associated Ig like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation[J]. Mol Immunol, 2005, 42(12): 1521-1530.
[15]
Tang X, Tian L, Esteso G, et al. Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype[J]. J Immunol, 2012, 188(2): 548-558.
